logo

Intec Pharma Ltd. (NTEC)



Trade NTEC now with
  Date
  Headline
3/13/2020 7:32:03 AM Intec Pharma FY Net Loss $47.6 Mln Or $1.41 Per Share Vs Loss $43.54 Mln Or $1.40 Per Share Last Year
1/9/2020 7:00:00 AM Intec Pharma Issues Letter to Shareholders (Press Release)
12/3/2019 7:35:00 AM Aspire Capital Commit To Buy Up To $10.0 Mln Of Intec Pharma's Ordinary Shares Over 30-month Period Extending Into 2022
11/12/2019 7:15:19 AM Intec Pharma Q3 Loss Per Share $0.61 Vs Loss $0.28 Last Year
9/25/2019 7:50:24 AM Intec Pharma Highlights Potential Of Accordion Pill Oral Drug Delivery Platform In Two Posters
8/9/2019 7:16:01 AM Intec Pharma Q2 Loss Per Share $0.30 Vs $0.34 Last Year
7/22/2019 7:05:59 AM Intec Pharma Says ACCORDANCE Study Did Not Achieve Statistical Superiority To Sinemet
6/25/2019 7:03:24 AM Intec Announces Results From Earlier Phase 2 Trial Of Accordion Pill-Carbidopa/Levodopa In Advanced Parkinson's Disease
6/19/2019 7:04:35 AM Intec Pharma Says Results From Pharmacokinetics Study Of AP-CD/LD 50/500 Mg Presented At The XXIV World Congress
5/20/2019 7:46:36 AM Intec Pharma Granted European Patent
5/20/2019 7:00:00 AM Intec Pharma Granted European Patent (Press Release)